BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32759993)

  • 1. New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.
    Alhebbi H; Peer-Zada AA; Al-Hussaini AA; Algubaisi S; Albassami A; AlMasri N; Alrusayni Y; Alruzug IM; Alharby E; Samman MA; Ayoub SZ; Maddirevula S; Peake RWA; Alkuraya FS; Wali S; Almontashiri NAM
    J Hum Genet; 2021 Feb; 66(2):151-159. PubMed ID: 32759993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel homozygous mutation in the USP53 gene as the cause of benign recurrent intrahepatic cholestasis in children: a case report.
    Ateş BB; Ceylan AC; Hızal G; Duran F; Doğan HT; Hızlı Ş
    Turk J Pediatr; 2023; 65(6):1012-1017. PubMed ID: 38204320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Two-Year Clinical Description of a Patient with a Rare Type of Low-GGT Cholestasis Caused by a Novel Variant of
    Shatokhina O; Semenova N; Demina N; Dadali E; Polyakov A; Ryzhkova O
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: Clinical, histological and ultrastructural characterization.
    Zhang J; Yang Y; Gong JY; Li LT; Li JQ; Zhang MH; Lu Y; Xie XB; Hong YR; Yu Z; Knisely AS; Wang JS
    Liver Int; 2020 May; 40(5):1142-1150. PubMed ID: 32124521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestasis Due to USP53 Deficiency.
    Bull LN; Ellmers R; Foskett P; Strautnieks S; Sambrotta M; Czubkowski P; Jankowska I; Wagner B; Deheragoda M; Thompson RJ
    J Pediatr Gastroenterol Nutr; 2021 May; 72(5):667-673. PubMed ID: 33075013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic Mutations in Ubiquitin-Specific Peptidase 53 (
    Vij M; Sankaranarayanan S
    Pediatr Dev Pathol; 2022; 25(2):207-212. PubMed ID: 34809518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants.
    Maddirevula S; Alhebbi H; Alqahtani A; Algoufi T; Alsaif HS; Ibrahim N; Abdulwahab F; Barr M; Alzaidan H; Almehaideb A; AlSasi O; Alhashem A; Hussaini HA; Wali S; Alkuraya FS
    Genet Med; 2019 May; 21(5):1164-1172. PubMed ID: 30250217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive Familial Intrahepatic Cholestasis Associated With USP53 Gene Mutation in a Brazilian Child.
    Porta G; Rigo PSM; Porta A; Pugliese RPS; Danesi VLB; Oliveira E; Borges CCV; Ribeiro C; Miura IK
    J Pediatr Gastroenterol Nutr; 2021 May; 72(5):674-676. PubMed ID: 33661244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel
    Ahn S; Choi J; Jeong SH
    Yonsei Med J; 2023 Dec; 64(12):745-749. PubMed ID: 37992747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield and novel candidate genes by next generation sequencing in 166 children with intrahepatic cholestasis.
    Zheng Y; Guo H; Chen L; Cheng W; Yan K; Zhang Z; Li M; Jin Y; Hu G; Wang C; Zhou C; Zhou W; Jia Z; Zheng B; Liu Z
    Hepatol Int; 2024 Apr; 18(2):661-672. PubMed ID: 37314652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.
    Mizuochi T; Kimura A; Tanaka A; Muto A; Nittono H; Seki Y; Takahashi T; Kurosawa T; Kage M; Takikawa H; Matsuishi T
    Clin Chim Acta; 2012 Aug; 413(15-16):1301-4. PubMed ID: 22525741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic loss-of-function
    Luan W; Hao CZ; Li JQ; Wei Q; Gong JY; Qiu YL; Lu Y; Shen CH; Xia Q; Xie XB; Zhang MH; Abuduxikuer K; Li ZD; Wang L; Xing QH; Knisely AS; Wang JS
    J Med Genet; 2021 Aug; 58(8):514-525. PubMed ID: 32737136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up.
    Helgadottir H; Folvik G; Vesterhus M
    Scand J Gastroenterol; 2023 May; 58(5):512-520. PubMed ID: 36369734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN).
    Lenz D; McClean P; Kansu A; Bonnen PE; Ranucci G; Thiel C; Straub BK; Harting I; Alhaddad B; Dimitrov B; Kotzaeridou U; Wenning D; Iorio R; Himes RW; Kuloğlu Z; Blakely EL; Taylor RW; Meitinger T; Kölker S; Prokisch H; Hoffmann GF; Haack TB; Staufner C
    Genet Med; 2018 Oct; 20(10):1255-1265. PubMed ID: 29419818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mutational Landscape Of Genetic Cholestatic Diseases In Pakistani Children.
    Cheema HA; Waheed N; Saeed A; Anjum MN; Fayyaz Z; Ijaz S
    J Pak Med Assoc; 2023 Aug; 73(8):1610-1621. PubMed ID: 37697751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
    Chen HL; Chang PS; Hsu HC; Lee JH; Ni YH; Hsu HY; Jeng YM; Chang MH
    Pediatr Res; 2001 Jul; 50(1):50-5. PubMed ID: 11420418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biallelic Novel
    Gezdirici A; Kalaycik Şengül Ö; Doğan M; Özgüven BY; Akbulut E
    Mol Syndromol; 2023 Jan; 13(6):471-484. PubMed ID: 36660033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum.
    van Ooteghem NA; Klomp LW; van Berge-Henegouwen GP; Houwen RH
    J Hepatol; 2002 Mar; 36(3):439-43. PubMed ID: 11867191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype.
    Matarazzo L; Bianco AM; Athanasakis E; Serveres M; Francalanci P; Cenacchi G; Maggiore G; D'Adamo AP
    J Pediatr Gastroenterol Nutr; 2022 May; 74(5):e115-e121. PubMed ID: 35129155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious Variants in ABCC12 are Detected in Idiopathic Chronic Cholestasis and Cause Intrahepatic Bile Duct Loss in Model Organisms.
    Pham DH; Kudira R; Xu L; Valencia CA; Ellis JL; Shi T; Evason KJ; Osuji I; Matuschek N; Pfuhler L; Mullen M; Mohanty SK; Husami A; Bull LN; Zhang K; Wali S; Yin C; Miethke A
    Gastroenterology; 2021 Jul; 161(1):287-300.e16. PubMed ID: 33771553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.